Supplementary Figure S12 from Circulating Tumor Cells Predict Response to the DLL3-Targeting Bispecific Antibody Tarlatamab
Year: 2026
Type: supplementary-materials
Abstract: Supplementary Figure S12 shows isoform characterization of DLL3 including protein structure, expression and isoform profiles for specific patients.
Authors: Avanish Mishra, Catherine B. Meador, Kruthika Kikkeri, Quinn Cunneely, Maoxuan Lin, Thomas J. Carmona-LaSalle, Shih-Bo Huang, Remy Bell, Victor Putaturo, Weikun Xia, Joyce H. Liang, Jacy Fang, Sarah San Vicente, Caroline E. Zielinski, Subba R. Digumarthy, Yin P. Hung, Beow Y. Yeap, Jon F. Edd, Michael S. Lawrence, Moshe Sade-Feldman, Debattama R. Sen, Mehmet Toner, Shyamala Maheswaran, Justin F. Gainor, Daniel A. Haber
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W7165204664
Cites:
Cited by:
Related to: